CHRONIC KIDNEY DISEASE ASSOCIATED WITH CHRONIC HEART FAILURE IN PATIENTS FROM THE CARDIOLOGY OUTPATIENT CLINIC

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

https://storage.unitedwebnetwork.com/files/1099/a2583d2e3641e1b02ebe40a0bb0215fe.pdf

Abstract Title *

CHRONIC KIDNEY DISEASE ASSOCIATED WITH CHRONIC HEART FAILURE IN PATIENTS FROM THE CARDIOLOGY OUTPATIENT CLINIC

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

HOSVEL ESPINOZA hosvelespinoza@gmail.com Hospital Dr. Mauricio Abdalah Nephrology Chinandega Nicaragua *

Co-author 2

Co-author 3

Co-author 4

Co-author 5

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Introduction

Chronic Kidney Disease (CKD) is a significant public health issue and one of the leading causes of morbidity and mortality worldwide, particularly in the Americas1. Identifying and understanding the impact of risk factors on the incidence of cardiorenal syndrome type 2 is of great importance.

Methods

This was an observational, analytical cohort study involving a population of 153 patients selected based on inclusion criteria. Frequency and percentage statistics were calculated, and graphs of disease association and progression were created using the statistical software SPSS (V. 30) and STATA (V. 17).

Results

The incidence of cardiorenal syndrome type 2 (CRS2) was 11.2%. There was a male predominance. Echocardiographic findings showed that valvular heart diseases, specifically those related to the mitral and tricuspid valves, as well as left ventricular hypertrophy, had a higher percentage of occurrence in patients with CRS2.

Conclusion

The incidence of cardiorenal syndrome type 2 in our study was 11.2% over a median follow-up of 875 days. No statistical association was identified with the risk factors studied.

Kewords